DAIICHI SANKYO Aktie
26,60EUR | -0,50EUR | -1,85% |
WKN: A0F57T / ISIN: JP3475350009
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 85,59 |
Nomura Asset Management Co., Ltd. | 5,19 |
Nippon Life Insurance Co. | 4,41 |
American Funds EuroPacific Growth Fund | 3,62 |
Daiichi Sankyo Co., Ltd. | 3,25 |
Asset Management One Co., Ltd. | 2,86 |
Nomura Asset NEXT FUNDS TOPIX ETF (1306) | 2,83 |
Vanguard Health Care Fund | 1,90 |
Government Pension Fund - Global (The) | 1,69 |
Nikko Asset Listed Index TOPIX ETF (1308) | 1,36 |
Mizuho Bank Pension Fund | 1,28 |
Shizuoka Financial Group, Inc. | 1,28 |
Mitsubishi UFJ Asset Management Co., Ltd. | 1,23 |
MS&AD Insurance Group Holdings, Inc. | 0,85 |
Sumitomo Mitsui Banking Pension Fund | 0,71 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 15 348 | 16 033 | 16 458 | 17 435 | 18 726 |
Umsatz pro Mitarbeiter in Mio. EUR | 63,97 | 60,03 | 63,49 | 73,33 | 85,53 |
Bilanz (in Mio. JPY) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 384 119 | 1 268 420 | 1 345 271 | 1 495 051 | 2 174 024 |
Summe Anlagevermögen | 721 500 | 816 758 | 876 131 | 1 013 838 | 1 287 111 |
Summe Aktiva | 2 105 619 | 2 085 178 | 2 221 402 | 2 508 889 | 3 461 135 |
Bilanz (in Mio. JPY) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 799 339 | 813 121 | 870 526 | 1 063 031 | 1 772 527 |
Summe Eigenkapital | 1 306 273 | 1 272 053 | 1 350 872 | 1 445 854 | 1 688 602 |
Summe Passiva | 2 105 612 | 2 085 174 | 2 221 398 | 2 508 885 | 3 461 129 |
Adresse
Daiichi Sankyo Head Office Bldg, A&B, 103-8426 Tokyo | |
Telefon | +81 (3) 6225-1111 |
Internet | https://www.daiichisankyo.co.jp |
Management
Akio Sakurai
Head-Sales & Marketing Division |
Akira Ogawa
Chief Financial Officer & Head-Global Planning |
Hiroto Kashiwasawa
General Manager-Technology |
Hiroyuki Okuzawa
President, COO & Representative Director |
James Felix
Chief Digital Transformation Officer |
Kazuaki Kama
Independent Outside Director |
Kenji Sato
Auditor |
Matt Allegrucci
Head-Global Compliance & Risk Management |
Miyuki Arai
Auditor |
Naoki Shimizu
Chief Quality Officer |
Naoto Tsukaguchi
General Counsel, Head-Global Legal & IP |
Nobuo Murakami
Senior Executive Officer & Manger-Corporate |
Satoshi Ogawa
Secretary |
Sawako Nohara
Independent Outside Director |
Shoji Hirashima
Representative Director & Senior Executive Officer |
Sunao Manabe
Executive Chairman & Chief Executive Officer |
Takaaki Nishii
Independent Outside Director |
Takashi Fukuoka
Director & Chief Strategy Officer |
Takashi Matsumoto
Director & Chief Human Resources Officer |
Terumichi Yokoyama
Head-Global Internal Audit |
Tetsuya Iwabuchi
Manager-Business Development |
Tomohiro Kodama
Manager-Accounting & Finance |
Ueno Shizuko
Senior Exceutive Officer & Head-Medical Affaris |
Yasuhiro Komatsu
Independent Outside Director |
Yo Honma
Independent Outside Director |
Yuki Abe
VP-Research & Development Division |